Core Viewpoint - The brain-computer interface (BCI) sector is gaining momentum, with significant developments from companies like Neuralink and BoRuiKang, indicating a potential boom in the market by 2026 [1][7]. Company Developments - Neuralink, founded by Elon Musk, aims for large-scale production of its devices by 2026, which has positively impacted global stock markets [1]. - BoRuiKang, a Chinese BCI company, is preparing for an IPO on the Sci-Tech Innovation Board after completing its counseling registration with the Shanghai Securities Regulatory Bureau [2]. - BoRuiKang's founder, Xu Honglai, has a strong academic background in biomedical engineering from Tsinghua University and has been pivotal in the company's development since its establishment in 2011 [3][4]. Product Innovations - BoRuiKang's notable product, the NEO system, utilizes a "semi-invasive" technique for brain interface implantation, which minimizes damage to neural tissue and avoids the need for batteries in the brain [4]. - The company has achieved significant milestones, including the first human implantation surgery in Shanghai in November 2024, with patients showing rapid recovery [4][5]. Market Trends - The global BCI market is projected to grow from $2.62 billion in 2024 to over $12.4 billion by 2034, with a compound annual growth rate (CAGR) of 17.35%, driven by the demand for treatments of neurological diseases and rehabilitation [8]. - In China, the BCI market is expected to reach 3.2 billion yuan in 2024, with projections of 6.14 billion yuan by 2028, indicating a doubling in four years [10]. Investment Landscape - BoRuiKang has attracted significant investment, with its valuation estimated between 3.5 billion to 4 billion yuan following its D-round financing [5]. - The company has received backing from prominent investors such as Sequoia China and Baidu Ventures, highlighting the growing interest in the BCI sector [4]. Competitive Landscape - The BCI industry is characterized by a mix of domestic and international players, with varying technological approaches. BoRuiKang focuses on both non-invasive and semi-invasive solutions, while competitors like Neuralink are exploring multi-channel flexible electrodes [12]. - The domestic market is witnessing a shift towards local production, with a current market share of 15-20% for domestic core devices, as companies like BoRuiKang lead in the non-invasive EEG collection segment [10][11].

Company Overview - Brain-computer interface company, BoRuiKang Technology (Shanghai) Co., Ltd., has completed its IPO counseling registration on February 4, 2026, with CITIC Securities as the counseling broker, marking the official start of its Sci-Tech Innovation Board IPO process [1][2][3] - Established in November 2011, BoRuiKang's core team includes experts from Tsinghua University's Neural Engineering Laboratory and clinical neuroscience, focusing on the research, production, and technical services of brain-computer interface systems [3][4] - The company has developed products for clinical diagnosis and research education, including digital EEG machines and transcranial electrical stimulation systems, with some products already receiving medical device registration [3][4] Product Development - BoRuiKang's flagship product, the NEO wireless minimally invasive brain-computer interface system, is the world's first to use an epidural implant with fully wireless transmission design [3][4] - NEO employs a "semi-invasive" technique, implanting coin-sized electrodes beneath the skull but outside the dura mater, allowing proximity to neurons without direct contact, thus avoiding damage to neural tissue [4] - The NEO system has undergone successful clinical trials, with 32 patients having completed implantation across 11 hospitals, achieving a 100% success rate in primary clinical endpoints [4][5] Regulatory Progress - NEO is set to submit a Class III innovative medical device registration application to the National Medical Products Administration, potentially becoming the first marketed implantable brain-computer interface product in China [5] - The product's first version, NEO 1.0, is expected to be followed by a 2.0 version that will include additional features such as language decoding and small limb decoding [5] Financial Backing and Valuation - BoRuiKang has completed multiple rounds of financing, with notable investors including Sequoia China and Baidu Ventures, achieving a post-investment valuation of 3.5 to 4 billion yuan by the end of 2025 [5][6] - The company has raised a total of 1.2 million yuan in angel funding and 30 million yuan in Pre-A funding, among other financing rounds [5] Industry Context - The brain-computer interface industry is experiencing significant growth opportunities in China, supported by favorable policies and market conditions [9][10] - The Ministry of Industry and Information Technology and other departments have included brain-computer interfaces in key future industry cultivation, with projections indicating the market could exceed 120 billion yuan by 2040 [10]